These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8406287)

  • 1. [Prevention of arteriosclerosis from the very beginning. Therapy with specific synergistic vitamins against hyperhomocysteinemia].
    Fortschr Med Suppl; 1993; 145():1-19. PubMed ID: 8406287
    [No Abstract]   [Full Text] [Related]  

  • 2. Homocysteine and arteriosclerosis: established risk factor or new illusion?
    Djuric D; Wisotzki R; Mitrovic V
    Am J Ther; 2000 Nov; 7(6):381-7. PubMed ID: 11304646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine, B vitamins, and atherosclerosis.
    Cheng TO
    Circulation; 1999 Jan; 99(3):459-60. PubMed ID: 9918639
    [No Abstract]   [Full Text] [Related]  

  • 4. [Homocysteine and cerebrovascular disease].
    Sepúlveda-Sánchez JM; Matía-Francés R; Martínez-Salio A; González-de la Aleja-Tejera J; Rodríguez-Peña Marín M; Porta-Etessam J
    Rev Neurol; 2004 Feb 16-29; 38(4):347-58. PubMed ID: 14997460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory action of statins and reduction of homocysteinemia by vitamin supplementation: interactions among strategies for cardiovascular prevention.
    Rubba P
    Nutr Metab Cardiovasc Dis; 2000 Aug; 10(4):173-6. PubMed ID: 11079254
    [No Abstract]   [Full Text] [Related]  

  • 6. [Homocysteine and atherosclerosis. The controlled clinical trials phase that people have been waiting for so long. Can multivitamins reduce coronary disease?].
    López Ridaura R
    Rev Invest Clin; 2000; 52(3):223-6. PubMed ID: 10953602
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hyperhomocysteinemia: risk factor for premature atheromatosis].
    Wautrecht JC
    Rev Med Brux; 1997 Jun; 18(3):103-6. PubMed ID: 9273596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyperhomocysteinemia: a new marker of vascular risk: affected vascular areas, its role in the pathogenesis of arteriosclerosis and thrombosis and treatment].
    Córdoba Porras A; Blanco Vaca F; González Sastre F
    Med Clin (Barc); 1997 Nov; 109(18):715-25. PubMed ID: 9499150
    [No Abstract]   [Full Text] [Related]  

  • 9. Homocysteine and stroke prevention: have the trials settled the issue?
    Spence JD
    Int J Stroke; 2006 Nov; 1(4):242-4. PubMed ID: 18706027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.
    Booth GL; Wang EE
    CMAJ; 2000 Jul; 163(1):21-9. PubMed ID: 10920726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperhomocysteinemia hastens myocardial infarct and stroke. Prevention.with leaf salads and vitamins].
    Meissner T
    MMW Fortschr Med; 2003 Mar; 145(10):10. PubMed ID: 12688018
    [No Abstract]   [Full Text] [Related]  

  • 12. Homocysteine: to screen and treat or to wait and see?
    Genest J; Audelin MC; Lonn E
    CMAJ; 2000 Jul; 163(1):37-8. PubMed ID: 10920728
    [No Abstract]   [Full Text] [Related]  

  • 13. Is plasma homocysteine a modifiable risk factor for stroke?
    Hankey GJ
    Nat Clin Pract Neurol; 2006 Jan; 2(1):26-33. PubMed ID: 16932518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of folic acid fortification and multivitamin therapy on homocysteine and vitamin B(12) status in cardiac transplant recipients.
    Miriuka SG; Langman LJ; Keren ES; Miner SE; Mamer OA; Delgado DH; Evrovski J; Ross HJ; Cole DE
    J Heart Lung Transplant; 2004 Apr; 23(4):405-12. PubMed ID: 15063399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine-lowering therapy and carotid intima-media thickness in renal transplant recipients.
    Marcucci R; Zanazzi M; Bertoni E; Rosati A; Fedi S; Lenti M; Prisco D; Castellani S; Abbate R; Salvadori M
    Transplant Proc; 2005; 37(6):2491-2. PubMed ID: 16182720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vitaminization of the diet as a way of raising the effectiveness of treating early manifestations of arteriosclerosis].
    Udalov IuF; Garashov BN; Bakhtadze NN
    Sov Med; 1971 Apr; 34(4):78-82. PubMed ID: 5143760
    [No Abstract]   [Full Text] [Related]  

  • 17. [Homocysteine--a routine biochemical parameter in cardiovascular diseases?].
    Gábor D; Hrnciar J; Hricová I; Zacharová M
    Vnitr Lek; 1999 Jan; 45(1):40-5. PubMed ID: 10422525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Homocysteine. The cardiovascular risk factor of the next millennium?].
    Suárez García I; Gómez Cerezo JF; Ríos Blanco JJ; Barbado Hernández FJ; Vázquez Rodríguez JJ
    An Med Interna; 2001 Apr; 18(4):211-7. PubMed ID: 11496543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine and risk for atherothrombotic events.
    Puddu P
    Cardiologia; 1999 Jul; 44(7):627-31. PubMed ID: 10476587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of vitamin therapy on the chemical factors of nervous excitation in the blood of patients with atherosclerosis].
    Monastyrskaia MT
    Vrach Delo; 1967 Dec; 12():113-5. PubMed ID: 4390391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.